Ifp Advisors, Inc Fulgent Genetics, Inc. Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	SELL	$21.55 - $29.29 $1,077 - $1,464	-50 Reduced 21.28%	185 $4,000
Q2 2023 Aug 04, 2023	BUY	$28.52 - $40.7 $1,426 - $2,035	50 Added 27.03%	235 $8,000
Q1 2023 Apr 18, 2023	SELL	$29.39 - $36.27 $382 - $471	-13 Reduced 6.57%	185 $5,000
Q4 2022 Feb 07, 2023	SELL	$29.23 - $40.28 $379 - $523	-13 Reduced 6.16%	198 $2,000
Q2 2022 Sep 06, 2022	BUY	$47.98 - $62.75 $10,123 - $13,240	211 New	211 $2,000
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $10,123 - $13,240	-211 Closed	0 $0
Q1 2022 Sep 06, 2022	SELL	$49.85 - $96.11 $747 - $1,441	-15 Reduced 6.64%	211 $13,000
Q1 2022 Aug 08, 2022	BUY	$49.85 - $96.11 $2,043 - $3,940	41 Added 22.16%	226 $14,000
Q4 2021 Jan 12, 2022	SELL	$77.3 - $105.0 $7,884 - $10,710	-102 Reduced 35.54%	185 $19,000
Q3 2021 Oct 06, 2021	BUY	$74.87 - $110.87 $10,107 - $14,967	135 Added 88.82%	287 $26,000
Q1 2021 Apr 30, 2021	BUY	$59.3 - $183.85 $4,388 - $13,604	74 Added 94.87%	152 $15,000
Q4 2020 Jan 25, 2021	BUY	$31.01 - $52.1 $2,418 - $4,063	78 New	78 $4,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.